Oncology News and Research

RSS
Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.
Study: Targeting specific genomic mutation in breast cancer improves survival

Study: Targeting specific genomic mutation in breast cancer improves survival

Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer

Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer

Targeted drug and hormone therapy combination extends breast cancer survival

Targeted drug and hormone therapy combination extends breast cancer survival

Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer

Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer

Study findings could set new standard of care for advanced anal cancer

Study findings could set new standard of care for advanced anal cancer

Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers

Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer

Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients

Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients

Educational initiatives needed to improve knowledge about biosimilars in oncology

Educational initiatives needed to improve knowledge about biosimilars in oncology

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Canon Medical to showcase world's first Ultra-High Resolution CT system at ASTRO 2018

Canon Medical to showcase world's first Ultra-High Resolution CT system at ASTRO 2018

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Prostate radiotherapy improves survival in men with low burden of metastatic disease

Prostate radiotherapy improves survival in men with low burden of metastatic disease